The once-daily pill has been developed by Novo Nordisk and is designed for adults living with obesity or those who are overweight and have weight-related health conditions
NHS and NICE-recommended weight management approaches including structured lifestyle interventions, behavioural support, and where appropriate, licensed pharmacological treatments such as orlistat or GLP-1 receptor agonists have a substantially stronger evidence base than L-carnitine supplements
& Patrick, J
These tools incorporate clinical risk factors including age, sex, BMI, previous fractures, family history, smoking status, and alcohol intake
$180 first month, $280/mo recurring (12-mo bundle) Compounded sema + tirz combo (Elite) $329 first month, $379/mo recurring (1-mo plan) Ozempic, Wegovy, Mounjaro, Zepbound Not offered INCLUDES Initial Lab Test Required and out of pocket